سعر ليفوستين 0.5 مجم بخاخ للانف 10 مل 2022

Livostin nasal spray: levocabastine 0.5 mg/ml (selective H1-antihistamine) nasal microsuspension, 10 ml, by Janssen-Cilag.

• Symptomatic treatment of seasonal or perennial allergic rhinitis.Population: Adults and children 6 years and overJohnson & Johnson Pacific (medsinfo.com.au)

• In 12 placebo-controlled trials (n=2328) reactions reported in at least 1% included headache (10.1% vs 11.9% placebo), pharyngolaryngeal pain (2.9%), somnolence (2.1%), fatigue (2.1%), sinusitis (1.8%), cough (1.7%), epistaxis (1.6%), nausea (1.3%), dizziness (1.3%) and pain (1.2%); application-site irritation, nasal discomfort and nasal congestion were reported in under 1%.International label, same formulation · Johnson & Johnson Pacific (medsinfo.com.au)

• Hypersensitivity to any of the ingredients.International label, same formulation · Johnson & Johnson Pacific (medsinfo.com.au)

• Not expected to interfere with driving or operating machinery, but caution is advised should drowsiness occur.International label, same formulation · Johnson & Johnson Pacific (medsinfo.com.au)

• Oxymetazoline (nasal decongestant)Oxymetazoline may transiently reduce the absorption of nasal levocabastine.Johnson & Johnson Pacific (medsinfo.com.au)

• Australian pregnancy category B3. Levocabastine crossed the placenta in rats; human risk is unknown and the PI states the nasal spray should not be used during pregnancy.International label, same formulation · Johnson & Johnson Pacific (medsinfo.com.au)
• About 0.6% of an intranasal dose was estimated to reach a breastfed infant; because data are limited, use during breastfeeding should be avoided.International label, same formulation · Johnson & Johnson Pacific (medsinfo.com.au)

• Levocabastine: Potent, selective histamine H1-receptor antagonist that competes with histamine at H1 receptors, preventing histamine-mediated allergic responses.